Innovation drives strategy at Actelion – discovery of the compound is followed by the search for medical applications made through a patient-oriented approach rather than traditional therapeutic area or market focus.
Innovation drives strategy at Actelion – discovery of the compound is followed by the search for medical applications made through a patient-oriented approach rather than traditional therapeutic area or market focus.
Actelion currently has four compounds in Phase III development. These compounds have the potential to change many patients lives by treating areas of high unmet medical need.
